JIUYUAN GENE, a biotechnology company, experienced a significant plummet of 33.98% in its stock price during Thursday's intraday trading session, following a disappointing trading debut on the Hong Kong Stock Exchange.
The company's shares opened at HK$7.50, a steep decline of nearly 40% from its initial public offering (IPO) price of HK$12.42. This weak debut performance contributed to the substantial drop in JIUYUAN GENE's stock value.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments